Polymerase Chain Reaction Technologies Market By Technology (Real-Time PCR, Traditional PCR, Digital PCR), By Product (Reagents & Consumables, Instruments, Software, Services), By End Users (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic & Research Institutions): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global polymerase chain reaction technology market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a huge consistent methodology in the molecular biological science that upgrades single or barely any copies of a piece of DNA. Similarly, it is valuable in making thousands to millions of copies of a particular DNA gathering and investigating ailments such as AIDS, tuberculosis, Lyme disorder, and center ear infections. The development incorporates three huge advances; denaturation, hardening, and extension. It is applicable in clinical, research, clinical diagnostics, and legitimate sciences. It has been utilized since seemingly forever as a standard method for research on nucleic acids (RNA and DNA) in labs. PCR progresses available in the market are nonstop quantitative (qPCR), mechanized PCR (dPCR), computerized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of strong illustrative diagnostic system in clinical consideration to perceive ailments empowers the premium for the advancement of the market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the polymerase chain reaction technologies market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the polymerase chain reaction technologies market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global polymerase chain reaction technologies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End Users
Diagnostic Centers Hospitals
Biotech Pharma Companies
Academic Research Institutions
By Technology
Real-Time PCR
Traditional PCR
Digital PCR
By Product
Reagents Consumables
Instruments
Software
Services
By Region
Europe
Germany
United Kingdom
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Rest of Asia-Pacific
North America
U.S.
Canada
Mexico
LAMEA
Latin America
Middle East
Africa
Key Market Players
AGILENT TECHNOLOGIES
INC
BIOMERIEUX S.A
BIO-RAD LABORATORIES
INC
F. HOFFMANN-LA ROCHE AG (ROCHE)
FLUIDIGM CORPORATION
LGC LIMITED
QIAGEN N.V
SYGNIS AG
TAKARA BIO INC
THERMO FISHER SCIENTIFIC INC
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook